Algert Global LLC Has $7.34 Million Stock Holdings in Agilon Health, Inc. $AGL

Key Points

• Algert Global LLC has reduced its stake in Agilon Health, Inc. by 19.6% to approximately 1.69 million shares, valued at about $7.34 million.
• Wall Street analysts have significantly adjusted their target prices for Agilon Health, with Barclays and Robert W. Baird lowering their targets to $1.50 and $1.00, respectively, indicating a generally bearish sentiment.
• Agilon Health reported a quarterly earnings miss, with an EPS of ($0.25) compared to the consensus estimate of ($0.11) and revenue down 5.9% year-over-year to $1.39 billion.

Algert Global LLC decreased its stake in shares of Agilon Health, Inc. (NYSE:AGL - Free Report) by 19.6% during the first quarter, according to the company in its most recent filing with the SEC. The fund owned 1,694,970 shares of the company's stock after selling 413,717 shares during the period. Algert Global LLC owned 0.41% of Agilon Health worth $7,339,000 as of its most recent filing with the SEC.

A number of other hedge funds have also made changes to their positions in the stock. SG Americas Securities LLC lifted its holdings in shares of Agilon Health by 1,271.3% during the first quarter. SG Americas Securities LLC now owns 144,189 shares of the company's stock worth $624,000 after buying an additional 133,674 shares during the last quarter. Wealth Enhancement Advisory Services LLC grew its position in Agilon Health by 21.8% in the first quarter. Wealth Enhancement Advisory Services LLC now owns 99,697 shares of the company's stock valued at $432,000 after acquiring an additional 17,866 shares during the period. Nisa Investment Advisors LLC boosted its stake in Agilon Health by 244.9% in the first quarter. Nisa Investment Advisors LLC now owns 9,553 shares of the company's stock worth $41,000 after purchasing an additional 6,783 shares in the last quarter. Price T Rowe Associates Inc. MD boosted its stake in Agilon Health by 41.0% in the fourth quarter. Price T Rowe Associates Inc. MD now owns 338,529 shares of the company's stock worth $644,000 after purchasing an additional 98,377 shares in the last quarter. Finally, Cerity Partners LLC acquired a new position in Agilon Health in the fourth quarter worth $34,000.

Analysts Set New Price Targets

Several equities analysts have recently issued reports on AGL shares. Evercore ISI cut their price target on Agilon Health from $5.00 to $3.00 and set an "in-line" rating on the stock in a research note on Wednesday, July 9th. Barclays lowered their price target on Agilon Health from $3.00 to $1.50 and set an "underweight" rating for the company in a report on Wednesday, August 6th. JMP Securities restated a "market perform" rating on shares of Agilon Health in a report on Monday, April 28th. Sanford C. Bernstein reiterated a "market perform" rating and set a $1.40 price objective (down from $4.00) on shares of Agilon Health in a report on Wednesday. Finally, The Goldman Sachs Group raised their price target on Agilon Health from $2.50 to $5.00 and gave the company a "neutral" rating in a research note on Thursday, May 8th. Four investment analysts have rated the stock with a Buy rating, twelve have assigned a Hold rating and two have given a Sell rating to the company's stock. According to MarketBeat.com, the stock currently has an average rating of "Hold" and an average price target of $3.07.

Agilon Health Stock Performance

NYSE:AGL traded up $0.0950 during mid-day trading on Friday, hitting $1.3250. 8,638,917 shares of the stock were exchanged, compared to its average volume of 22,113,372. The stock has a market capitalization of $549.11 million, a price-to-earnings ratio of -1.72 and a beta of 0.14. The firm's 50-day simple moving average is $1.86 and its 200 day simple moving average is $2.99. Agilon Health, Inc. has a fifty-two week low of $0.71 and a fifty-two week high of $6.08.

Agilon Health (NYSE:AGL - Get Free Report) last released its quarterly earnings results on Monday, August 4th. The company reported ($0.25) earnings per share for the quarter, missing the consensus estimate of ($0.11) by ($0.14). The firm had revenue of $1.39 billion for the quarter, compared to analyst estimates of $1.47 billion. Agilon Health had a negative return on equity of 66.76% and a negative net margin of 5.35%.The business's revenue for the quarter was down 5.9% on a year-over-year basis. During the same period in the previous year, the business posted ($0.07) earnings per share. On average, analysts predict that Agilon Health, Inc. will post -0.59 EPS for the current fiscal year.

About Agilon Health

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.